A team of scientists based at CSIR-Centre for Cellular and Molecular Biology (CCMB) in Hyderabad, India has solved an important piece of how cells build their internal skeleton. Using cryo-electron microscopy, the researchers showed how a protein called SPIN90 forms a pair and activates the Arp2/3 complex to start new actin filaments. This work explains a long-standing mystery about how straight actin filaments can be made inside cells and helps us understand cell movement, shape and some disease processes. This is Indian scientists SPIN90 Arp2/3 discovery.
What did the researchers find?
Cells use long thin proteins called actin to make structures that help them move, divide and keep their shape. The Arp2/3 complex is a molecular machine that helps start (nucleate) actin filaments. Until now, scientists knew Arp2/3 could make branched actin networks, but they did not fully understand how a class of helper proteins called WDS (which includes SPIN90) makes the Arp2/3 complex produce straight, linear actin filaments instead of branches. The new study shows that SPIN90 forms a dimer — two SPIN90 molecules joined together — and this dimer binds to Arp2/3 in a way that pushes the complex into an “active” shape that can nucleate linear filaments.
Why that matters — a real-world analogy
Think of actin filaments as the wooden beams used to build a temporary shelter. The Arp2/3 complex is like a tool that can start those beams growing from one point. SPIN90 is like a pair of hands that holds the tool at just the right angle so the first beam can be formed straight rather than branching off. The researchers showed that a single SPIN90 dimer can even link two Arp2/3 tools, allowing beams to be started in two directions at once. That helps explain how cells can quickly build different shapes and networks when they need to move or change. And, this is the story of Indian scientists SPIN90 Arp2/3 discovery.
How they proved it
The team used cryo-electron microscopy (cryo-EM), a method that freezes molecules very fast and images them at near-atomic detail. The images revealed how SPIN90 contacts specific parts of the Arp2/3 complex and how that interaction forces the complex to adopt the active conformation needed to form new filaments. The researchers also combined biochemical experiments to show the SPIN90 dimer drives the structural changes in Arp2/3 that let it work as a nucleator of linear actin.
Who led the work
The study was led from CSIR-CCMB (Hyderabad) with contributions from the University of Oregon. Several members of the team are affiliated with Indian research institutions, including Justus Francis, Achyutha Krishna Pathri, Kankipati Teja Shyam, Sridhar Sripada, Kiran Vyshnav Eliyan and Saikat Chowdhury. The project was supervised by Saikat Chowdhury and involved close collaboration with US researchers. The authors deposited their structural data to public databases for other scientists to use.
What this could mean for medicine and biology
Understanding how actin filaments are nucleated is important for many reasons:
- Cell movement and immune responses depend on actin. A clearer picture of how actin is built can help explain how immune cells chase and capture bacteria.
- Cancer cells use actin rearrangements to move and invade. Better knowledge of these mechanisms may suggest new strategies to block cancer spread.
- Some genetic diseases affect actin regulation. Knowing the molecular details could help in designing targeted therapies in the long term.
These are possible directions, not immediate cures. Basic structural studies like this provide the blueprints scientists need before they can design drugs or treatments.
Simple example to make it stick
Imagine you want to start making a straight fence using long planks. You could try to start planks randomly and hope they line up. Or you could use a starter jig that holds the first two planks exactly where you want them. SPIN90 acts like that starter jig: it holds and shapes the Arp2/3 complex so it makes straight filaments reliably. Without the jig, you might still get pieces of fence, but they would be disorganized. With the jig, you get a straight, stable section you can build from.
Key technical takeaways (short)
- SPIN90 forms a dimer through a specific middle region.
- The SPIN90 dimer engages parts of the Arp2/3 complex and forces conformational changes that mimic a two-actin-unit arrangement, enabling nucleation.
- A single SPIN90 dimer can bridge two Arp2/3 complexes, which may allow rapid, bidirectional filament nucleation.
Funding and resources
The work was supported by CSIR grants and computational and microscopy support from CSIR-CCMB facilities. The authors also note NIH funding for collaborators. This mix of local infrastructure and international collaboration illustrates how complex structural biology studies often require both advanced instruments and cross-border teamwork.
Why Indian science getting this result is noteworthy
High-resolution structural biology requires not only technical skill but also expensive infrastructure and teamwork. That the bulk of this work — from sample preparation to cryo-EM data collection and model building — involved scientists at an Indian national lab shows increasing local capacity for world-class molecular research. This helps build scientific independence and gives young Indian researchers a chance to lead in fields that matter for health and biotechnology.
Final note
This study answers a detailed molecular question: how SPIN90 activates the Arp2/3 complex to start straight actin filaments. The result is a clear structural map and a simple mechanism that other researchers can now use. For the public, the headline is straightforward: Indian researchers helped reveal how a cellular “starter” proteins pair up and switch on a key builder inside cells. That knowledge is an important step toward understanding cell shape, movement and, ultimately, diseases that involve these processes.
Source: Nature
Read more about CRISPR gene editing here.
Discover more from Science Buzzer
Subscribe to get the latest posts sent to your email.

Leave a Reply